Market Closed -
Australian S.E.
02:10:05 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
2.53
AUD
|
+2.43%
|
|
-0.39%
|
+32.81%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
496.3
|
759.3
|
1,033
|
694.1
|
764.3
|
591.8
|
-
|
-
|
Enterprise Value (EV)
1 |
615.4
|
883.7
|
1,170
|
911.9
|
1,096
|
826.6
|
824.8
|
821
|
P/E ratio
|
23.8
x
|
31.1
x
|
33.3
x
|
43.9
x
|
30.9
x
|
-12.3
x
|
24.3
x
|
18.9
x
|
Yield
|
3.16%
|
2.44%
|
2.4%
|
2.31%
|
1.83%
|
2.49%
|
3.18%
|
3.97%
|
Capitalization / Revenue
|
2.14
x
|
2.77
x
|
2.94
x
|
1.92
x
|
1.73
x
|
1.25
x
|
1.17
x
|
1.11
x
|
EV / Revenue
|
2.65
x
|
3.22
x
|
3.33
x
|
2.53
x
|
2.49
x
|
1.74
x
|
1.64
x
|
1.54
x
|
EV / EBITDA
|
11.6
x
|
13.8
x
|
12.5
x
|
12.2
x
|
12.9
x
|
9.08
x
|
7.96
x
|
7.2
x
|
EV / FCF
|
-
|
15.9
x
|
23.7
x
|
97.7
x
|
40
x
|
33.2
x
|
25.9
x
|
20.4
x
|
FCF Yield
|
-
|
6.3%
|
4.21%
|
1.02%
|
2.5%
|
3.02%
|
3.87%
|
4.89%
|
Price to Book
|
3.9
x
|
3.33
x
|
4.05
x
|
2
x
|
2.05
x
|
1.85
x
|
1.82
x
|
1.75
x
|
Nbr of stocks (in thousands)
|
157,066
|
194,684
|
198,629
|
229,071
|
233,029
|
233,916
|
-
|
-
|
Reference price
2 |
3.160
|
3.900
|
5.200
|
3.030
|
3.280
|
2.470
|
2.470
|
2.470
|
Announcement Date
|
8/25/19
|
8/24/20
|
8/26/21
|
8/28/22
|
8/27/23
|
-
|
-
|
-
|
Fiscal Period: Giugno |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
232.4
|
274.1
|
351
|
361
|
440.8
|
475
|
503.7
|
533.8
|
EBITDA
1 |
53
|
64.1
|
93.5
|
74.8
|
85.2
|
91.07
|
103.6
|
114.1
|
EBIT
1 |
42
|
49.3
|
58.59
|
38.1
|
43.8
|
46.58
|
56.32
|
65.64
|
Operating Margin
|
18.07%
|
17.99%
|
16.69%
|
10.56%
|
9.94%
|
9.81%
|
11.18%
|
12.3%
|
Earnings before Tax (EBT)
1 |
30.62
|
35.26
|
45.22
|
22.56
|
30.63
|
-13.1
|
34.62
|
45
|
Net income
1 |
20.98
|
23
|
31.27
|
14.6
|
25.04
|
-49.69
|
23.73
|
31.68
|
Net margin
|
9.03%
|
8.39%
|
8.91%
|
4.05%
|
5.68%
|
-10.46%
|
4.71%
|
5.94%
|
EPS
2 |
0.1329
|
0.1253
|
0.1560
|
0.0690
|
0.1060
|
-0.2003
|
0.1016
|
0.1305
|
Free Cash Flow
1 |
-
|
55.7
|
49.31
|
9.33
|
27.42
|
24.93
|
31.9
|
40.17
|
FCF margin
|
-
|
20.32%
|
14.05%
|
2.58%
|
6.22%
|
5.25%
|
6.33%
|
7.53%
|
FCF Conversion (EBITDA)
|
-
|
86.9%
|
52.74%
|
12.47%
|
32.19%
|
27.37%
|
30.8%
|
35.22%
|
FCF Conversion (Net income)
|
-
|
242.17%
|
157.71%
|
63.89%
|
109.52%
|
-
|
134.45%
|
126.81%
|
Dividend per Share
2 |
0.1000
|
0.0950
|
0.1250
|
0.0700
|
0.0600
|
0.0614
|
0.0786
|
0.0981
|
Announcement Date
|
8/25/19
|
8/24/20
|
8/26/21
|
8/28/22
|
8/27/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
131.8
|
-
|
170.7
|
179.1
|
180.5
|
179.3
|
215.7
|
225.1
|
231.3
|
244.6
|
247.6
|
265
|
EBITDA
1 |
29.3
|
34.8
|
52
|
41.5
|
39.5
|
35.3
|
39.8
|
45.4
|
43.2
|
49.6
|
50.2
|
57
|
EBIT
1 |
21.94
|
27.36
|
35
|
23.59
|
22.03
|
16.07
|
19.66
|
24.2
|
21.2
|
25.9
|
27.2
|
33.7
|
Operating Margin
|
16.64%
|
-
|
20.5%
|
13.17%
|
12.2%
|
8.96%
|
9.11%
|
10.75%
|
9.17%
|
10.59%
|
10.99%
|
12.72%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
16.39
|
-
|
-
|
18.48
|
12.15
|
-65.77
|
16.1
|
16
|
23.2
|
Net income
1 |
10.9
|
12.1
|
19.9
|
11.37
|
10.2
|
4.403
|
16.14
|
8.903
|
-66.8
|
9.25
|
11.6
|
16.7
|
Net margin
|
8.27%
|
-
|
11.66%
|
6.35%
|
5.65%
|
2.46%
|
7.48%
|
3.96%
|
-28.88%
|
3.78%
|
4.68%
|
6.3%
|
EPS
2 |
-
|
-
|
-
|
0.0562
|
-
|
0.0187
|
-
|
0.0375
|
-0.2862
|
0.0490
|
0.0490
|
0.0710
|
Dividend per Share
2 |
0.0550
|
0.0400
|
0.0550
|
0.0700
|
-
|
0.0300
|
0.0250
|
0.0350
|
0.0250
|
0.0350
|
0.0340
|
0.0500
|
Announcement Date
|
2/19/20
|
8/24/20
|
2/21/21
|
8/26/21
|
2/22/22
|
8/28/22
|
2/16/23
|
8/27/23
|
2/19/24
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
119
|
124
|
137
|
218
|
331
|
235
|
233
|
229
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.246
x
|
1.941
x
|
1.47
x
|
2.912
x
|
3.888
x
|
2.578
x
|
2.249
x
|
2.009
x
|
Free Cash Flow
1 |
-
|
55.7
|
49.3
|
9.33
|
27.4
|
24.9
|
31.9
|
40.2
|
ROE (net income / shareholders' equity)
|
23.2%
|
17.6%
|
12.9%
|
4.85%
|
6.95%
|
0.91%
|
8.14%
|
10.2%
|
ROA (Net income/ Total Assets)
|
10%
|
6.97%
|
5.04%
|
2.03%
|
3.09%
|
2.38%
|
4.6%
|
5.86%
|
Assets
1 |
209.1
|
330
|
620.9
|
719
|
811
|
-2,086
|
515.6
|
540.7
|
Book Value Per Share
2 |
0.8100
|
1.170
|
1.280
|
1.520
|
1.600
|
1.340
|
1.360
|
1.410
|
Cash Flow per Share
2 |
0.2100
|
0.2900
|
0.3500
|
0.1800
|
0.3000
|
0.2600
|
0.3100
|
0.3300
|
Capex
1 |
18.7
|
26.1
|
20.3
|
27.8
|
44
|
34.3
|
37.3
|
39.3
|
Capex / Sales
|
8.03%
|
9.52%
|
5.77%
|
7.69%
|
9.98%
|
7.22%
|
7.4%
|
7.36%
|
Announcement Date
|
8/25/19
|
8/24/20
|
8/26/21
|
8/28/22
|
8/27/23
|
-
|
-
|
-
|
Last Close Price
2.47
AUD Average target price
2.523
AUD Spread / Average Target +2.15% Consensus |
1st Jan change
|
Capi.
|
---|
| +32.81% | 377M | | -16.58% | 8.25B | | +40.06% | 3.58B | | -39.11% | 2.46B | | -7.36% | 2.46B | | -8.95% | 2.38B | | -8.41% | 1.81B | | -19.68% | 1.55B | | -40.66% | 1.21B | | +7.56% | 1.11B |
Medical & Diagnostic Laboratories
|